Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Infect Control. 2012 Nov;40(9):886-7. doi: 10.1016/j.ajic.2011.11.005. Epub 2012 Feb 22.

Risk factors associated with linezolid-nonsusceptible enterococcal infections.

Author information

1
College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, OR 97239, USA. mcgregoj@ohsu.edu

Abstract

Linezolid is one of few treatment options available for vancomycin-resistant enterococci. The present study investigated risk factors for linezolid-nonsusceptible enterococci using a case-control study of 15 cases and 60 control patients. Previous hospitalization, admission to a medical service, comorbidity, and linezolid and sulfonamide therapy were identified as risk factors.

PMID:
22361358
PMCID:
PMC3644997
DOI:
10.1016/j.ajic.2011.11.005
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center